Abstract
We report the case of a 57-year-old woman with ulcerative colitis since eight years who developed a diffuse interstitial pneumonia linked to mesalazine (oral and enemas). The adverse drug-related effect to mesalazine was strongly suggested regarding improvement upon discontinuation and relapse after reinstitution of mesalazine. To date, after 8 years, the patient has not any respiratory symptom which is another argument for the adverse drug-related effect to mesalazine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
